Financial News

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Enters Agreement to Monetize Legacy Assets

Safety Shot (NASDAQ: SHOT) today announced that it has signed an agreement to license and sell its legacy Jupiter Wellness assets to Colorado-based Elite Health Partners Inc., a leading provider of world-class, innovative products and services that fulfill a broad range of consumer health and beauty needs globally. According to the announcement, Elite Health, currently a private company, plans to file a registration statement for an IPO by Q3 2024 and subsequently become publicly listed. The announcement further stated that upon its IPO, Elite Health intends to acquire the licensed Jupiter Wellness assets for a consideration of 40% of Elite Health’s outstanding shares that Safety Shot plans to dividend to its shareholders. Safety Shot’s Jupiter Wellness assets include a portfolio of over-the-counter commercialized products as well as product candidates in development for indications such as skin care, hair growth and women’s health.

“Elite Health, combined with our Jupiter Wellness portfolio, is set to become a wellness powerhouse that develops, manufactures, launches, markets and distributes a portfolio of high-quality products,” said Safety Shot CEO Brian John. “This deal with Elite Health is a great way for Safety Shot to monetize our assets, further freeing us up to focus solely on Safety Shot’s enormous opportunity in the functional beverage industry.”

To view the full press release, visit https://ibn.fm/otbsJ

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Safety Shot is available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback